Article ID Journal Published Year Pages File Type
5898683 Diabetes Research and Clinical Practice 2016 8 Pages PDF
Abstract
Current evidence suggests that higher baseline HbA1c is associated with a greater efficacy of both DPP-4I and GLP-1A therapies in lowering HbA1c. The roles of other potential predictors are less consistent across studies and require further investigation.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology
Authors
, , , ,